Amoy Diagnostics Co Ltd (300685):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Amoy Diagnostics Co Ltd (300685) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7906
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Amoy Diagnostics Co Ltd (AmoyDx) is a developer of molecular diagnostics for oncology precision medicine. The company provides gene mutation products such as mutation detection kit and gene fusions detection kit. It offers nucleic acid extraction products including DNA and RNA extraction kits. AmoyDx also provides super-ARMS EGFR mutation detection kit, HER-2 gene amplification analysis kit, HPV detection kit, human papillomavirus genotyping detection kit, and high-risk human papillomavirus detection kit. The company’s products are used for the treatment and diagnostics of lung cancer, colon cancer, and leukemia. It serves domestic and international oncology sector. The company markets its products through a network of distributors in Argentina, Iceland, Norway, Sweden, Austria, Ireland, the Philippines, Switzerland, and Belgium, among other countries. AmoyDx is headquartered in Xiamen, China.

Amoy Diagnostics Co Ltd (300685) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Amoy Diagnostics Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Amoy Diagnostics Co Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Amoy Diagnostics Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Amoy Diagnostics Co Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Amoy Diagnostics Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Amoy Diagnostics Co Ltd, Medical Equipment, Deal Details 10
Partnerships 10
CANbridge Life Sciences and Amoy Diagnostics Enter into Agreement 10
Merck Enters into Co-Development Agreement with Amoy Diagnostics 11
MoBiTec Enters into Distribution Agreement with Amoy Diagnostics 12
Amoy Diagnostics Enters Into Agreement With OxOnc Development For Gene Fusions Detection Kits 13
Equity Offering 14
Amoy Diagnostics Raises USD41.2 Million in IPO 14
Amoy Diagnostics Co Ltd – Key Competitors 15
Amoy Diagnostics Co Ltd – Key Employees 16
Amoy Diagnostics Co Ltd – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Amoy Diagnostics Co Ltd, Medical Equipment, Key Facts, 2017 2
Amoy Diagnostics Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Amoy Diagnostics Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Amoy Diagnostics Co Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Amoy Diagnostics Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Amoy Diagnostics Co Ltd, Deals By Market, 2012 to YTD 2018 8
Amoy Diagnostics Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
CANbridge Life Sciences and Amoy Diagnostics Enter into Agreement 10
Merck Enters into Co-Development Agreement with Amoy Diagnostics 11
MoBiTec Enters into Distribution Agreement with Amoy Diagnostics 12
Amoy Diagnostics Enters Into Agreement With OxOnc Development For Gene Fusions Detection Kits 13
Amoy Diagnostics Raises USD41.2 Million in IPO 14
Amoy Diagnostics Co Ltd, Key Competitors 15
Amoy Diagnostics Co Ltd, Key Employees 16

List of Figures
Amoy Diagnostics Co Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Amoy Diagnostics Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Amoy Diagnostics Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Amoy Diagnostics Co Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Amoy Diagnostics Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Amoy Diagnostics Co Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Amoy Diagnostics Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Amoy Diagnostics Co Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Amoy Diagnostics Co Ltd (300685):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • AstraZeneca Plc (AZN):企業の財務・戦略的SWOT分析
    AstraZeneca Plc (AZN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Medivir AB (MVIR B):企業の財務・戦略的SWOT分析
    Summary Medivir AB (Medivir) is a drug discovery and development company focusing on transformative cancer drugs. The company offers products under development for the treatment of cutaneous T-cell lymphoma, osteoarthritis, solid tumors, hepatocellular carcinoma and RSV-infection. Medivir also provi …
  • Kitov Pharmaceuticals Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Kitov Pharmaceuticals Ltd (Kitov Pharmaceuticals) a subsidiary of Kitov Pharma Ltd, is a biopharmaceutical company with focus on drug development. Its pipeline therapeutic candidates include Consensi, a combination drug with celecoxib and amlodipine besylate as active ingredients for the tre …
  • Northern Ireland Electricity Networks Ltd:企業の戦略的SWOT分析
    Northern Ireland Electricity Networks Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Glory Ltd:企業の戦略・SWOT・財務分析
    Glory Ltd - Strategy, SWOT and Corporate Finance Report Summary Glory Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • PDS Biotechnology Corp-製薬・医療分野:企業M&A・提携分析
    Summary PDS Biotechnology Corp (PDS Biotechnology) is a biopharmaceutical company that develops immunotherapies and vaccines for cancer and infectious disease. The company uses versamune technology, which is immunostimulatory nanoparticle vaccine platform used for the development of cancer immunothe …
  • Monex Group, Inc.:企業の戦略・SWOT・財務情報
    Monex Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Monex Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Inchcape plc (INCH):企業の財務・戦略的SWOT分析
    Inchcape plc (INCH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • PT Ramayana Lestari Sentosa Tbk:戦略・SWOT・企業財務分析
    PT Ramayana Lestari Sentosa Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Ramayana Lestari Sentosa Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Medizone International Inc (MZEI):企業の財務・戦略的SWOT分析
    Summary Medizone International Inc (Medizone) is a medical device company that develops aseptic treatment. The company provides disinfectant products used in surgical and other medical treatment facilities. Its product includes AsepticSure hospital sterilization system. Medizone’s AsepticSure is an …
  • Securitas AB (SECU B):企業の財務・戦略的SWOT分析
    Securitas AB (SECU B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Charter Hall Group:企業のM&A・事業提携・投資動向
    Charter Hall Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Charter Hall Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • The Economist Group Ltd:企業の戦略的SWOT分析
    The Economist Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Orpea SA (ORP):企業の財務・戦略的SWOT分析
    Summary Orpea SA (Orpea) is a healthcare consulting company that offers clinical care services. The company provides services such as suite care clinic services, retirement homes, and mental hospital services, among others. Its mental hospital services include treatment of mood disorders, overuse sy …
  • DH Private Equity Partners:企業の戦略・SWOT・財務分析
    DH Private Equity Partners - Strategy, SWOT and Corporate Finance Report Summary DH Private Equity Partners - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Fortune Electric Co Ltd (1519):企業の財務・戦略的SWOT分析
    Summary Fortune Electric Co Ltd (Fortune Electric) is a power company that manufactures and markets transformers and accessories. The company provides products such as distribution transformers, power transformers, cast resin transformers and amorphous metal alloy core transformers, among others. It …
  • Portland General Electric Co (POR):企業の財務・戦略的SWOT分析
    Portland General Electric Co (POR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Orlando Utilities Commission:企業の戦略的SWOT分析
    Orlando Utilities Commission - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Procaps SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary Procaps SAS (Procaps) is a manufacturing and commercializing company that provides pharmaceutical forms. The company provides softigel products such as RX products, OTC products, natural products, omega 3 fish oils, gummies and veterinary products, among others. Its hospitalaria unit offers …
  • SOCOMEC Group:企業の戦略的SWOT分析
    SOCOMEC Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆